Subscribe to this collection to receive daily e-mail notification of new additions

Preview	Issue Date	Title	Author(s)
	2022	Recent breakthroughs and future directions in drugging aquaporins	Salman, M.M.; Kitchen, P.; Yool, A.J.; Bill, R.M.
	2022	Examining the cost and impact of dosing fees among clients in opioid agonist treatment: results from a cross-sectional survey of Australian treatment clients	Zahra, E.; Chen, R.; Nielsen, S.; Tran, A.D.; Santo, T.; Degenhardt, L.; Farrell, M.; Byrne, J.; Ali, R.; Larance, B.
	2022	Review article: the future of microbiome-based therapeutics	Gulliver, E.L.; Young, R.B.; Chonwerawong, M.; D'Adamo, G.L.; Thomason, T.; Widdop, J.T.; Rutten, E.L.; Rossetto Marcelino, V.; Bryant, R.V.; Costello, S.P.; O'Brien, C.L.; Hold, G.L.; Giles, E.M.; Forster, S.C.
	2022	The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)	Elias, A.K.; Wilson, M.R.; Carver, J.A.; Musgrave, I.F.
	2022	Fc gamma receptor is not required for in vivo processing of radio- and drug-conjugates of the dead tumor cell-targeting monoclonal antibody, APOMAB®	Staudacher, A.H.; Liapis, V.; Wittwer, N.L.; Tieu, W.; Lam, H.C.; Leusen, J.; Brown, M.P.
	2021	Endocannabinoids in bladder sensory mechanisms in health and diseases	Christie, S.; Brookes, S.; Zagorodnyuk, V.
	2021	Treatment of cystic fibrosis: from gene- to cell-based therapies	Allan, K.M.; Farrow, N.; Donnelley, M.; Jaffe, A.; Waters, S.A.
	2021	Are sarcopenia and cognitive dysfunction comorbid after stroke in the context of brain–muscle crosstalk?	Sui, S.X.; Hordacre, B.; Pasco, J.A.
	2021	Emerging benefits and drawbacks of α₂-adrenoceptor agonists in the management of sepsis and critical illness	Lankadeva, Y.R.; Shehabi, Y.; Deane, A.M.; Plummer, M.P.; Bellomo, R.; May, C.N.
	2021	Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion	Nguyen, W.; Dans, M.G.; Ngo, A.; Gancheva, M.R.; Romeo, O.; Duffy, S.; de Koning-Ward, T.F.; Lowes, K.N.; Sabroux, H.J.; Avery, V.M.; Wilson, D.W.; Gilson, P.R.; Sleebs, B.E.
	2021	Residential medication management reviews in Australian residential aged care facilities	Sluggett, J.K.; Bell, J.S.; Lang, C.; Corlis, M.; Whitehead, C.; Wesselingh, S.L.; Inacio, M.C.
	2021	Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C9 and HLA-B genotypes and phenytoin dosing: 2020 update	Karnes, J.H.; Rettie, A.E.; Somogyi, A.A.; Huddart, R.; Fohner, A.E.; Formea, C.M.; Lee, M.T.M.; Llerena, A.; Whirl-Carrillo, M.; Klein, T.E.; Phillips, E.J.; Mintzer, S.; Gaedigk, A.; Caudle, K.E.; Callaghan, J.T.
	2021	Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions	Pisanu, C.; Congiu, D.; Severino, G.; Ardau, R.; Chillotti, C.; Del Zompo, M.; Baune, B.T.; Squassina, A.
	2021	The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study	Bharat, C.; Larney, S.; Barbieri, S.; Dobbins, T.; Jones, N.R.; Hickman, M.; Gisev, N.; Ali, R.; Degenhardt, L.
	2021	Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy	Crews, K.R.; Monte, A.A.; Huddart, R.; Caudle, K.E.; Kharasch, E.D.; Gaedigk, A.; Dunnenberger, H.M.; Leeder, J.S.; Callaghan, J.T.; Samer, C.F.; Klein, T.E.; Haidar, C.E.; Van Driest, S.L.; Ruano, G.; Sangkuhl, K.; Cavallari, L.H.; Müller, D.J.; Prows, C.A.; Nagy, M.; Somogyi, A.A.; et al.
	2021	Emerging therapeutic applications for fumarates	Hoogendoorn, A.; Avery, T.D.; Li, J.; Bursill, C.; Abell, A.; Grace, P.M.
	2021	In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens	Nguyen, H.T.; Venter, H.; Veltman, T.; Williams, R.; Anne O'Donovan, L.; Russell, C.C.; McCluskey, A.; Page, S.W.; Ogunniyi, A.D.; Trott, D.J.
	2021	Comparison of two transmission electron microscopy methods to visualize drug-induced alterations of gram-negative bacterial morphology	Nguyen, H.T.; O’Donovan, L.; Venter, H.; Russell, C.C.; McCluskey, A.; Page, S.W.; Trott, D.J.; Ogunniyi, A.D.
	2021	Approaches to introduce helical structure in cysteine-containing peptides with a bimane group	Horsfall, A.J.; McDougal, D.P.; Scanlon, D.B.; Bruning, J.B.; Abell, A.D.
	2021	Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy	Shukla, S.D.; Taylor, S.L.; Gibson, P.G.; Barker, D.; Upham, J.W.; Yang, I.A.; Reynolds, P.N.; Hodge, S.; James, A.L.; Rogers, G.B.; Simpson, J.L.